16 results
DEF 14A
BOLT
Bolt Biotherapeutics Inc
28 Apr 22
Definitive proxy
4:06pm
basic financial statements, being over 21 years of age and having the highest personal integrity and ethics. The nominating and corporate governance … . Healy, Richard A. Miller, and Nicole Onetto. The chairperson of our research and development committee is Dr. Onetto.
Code of Business Conduct and Ethics
10-K
bzjpwxh7y
31 Mar 21
Annual report
4:06pm
424B4
zyzy4wpq70helukg
5 Feb 21
Prospectus supplement with pricing info
4:44pm
S-1/A
xyh2y9fu69mnk5p
1 Feb 21
IPO registration (amended)
6:24am
S-1
EX-10.14
yhx88x2c
15 Jan 21
IPO registration
3:58pm
S-1
8zz lkdscvpa
15 Jan 21
IPO registration
3:58pm
DRS/A
3a8dvepj44u0pvnr
11 Jan 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.14
p6e45d6u
11 Sep 20
Draft registration statement (amended)
12:00am
DRS/A
3vb1c8p9c6y1 oa7kfww
11 Sep 20
Draft registration statement (amended)
12:00am
DRS
eu38kl9i6zu4pk6a
10 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next